See the DrugPatentWatch profile for tigecycline

Tigecycline is an antibiotic used to treat a variety of bacterial infections, including pneumonia, skin infections, and intra-abdominal infections [1]. When it comes to pregnancy, the U.S. Food and Drug Administration (FDA) classifies medications into categories A, B, C, D, and X based on their risk profile during pregnancy [2].

According to the FDA, tigecycline is classified as a pregnancy category D drug [3]. This means that there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks [2].

It is important to note that the use of tigecycline during pregnancy should be carefully considered and discussed with a healthcare provider [3]. The decision to use this medication should be based on the specific clinical circumstances and the potential risks and benefits to both the mother and the fetus [2].

In summary, tigecycline is classified as a pregnancy category D drug, indicating that there is positive evidence of human fetal risk. However, the use of this medication during pregnancy may be warranted in certain situations based on a careful risk-benefit assessment.

Sources:
[1] "Tigecycline." MedlinePlus, U.S. National Library of Medicine, 11 Feb. 2022, medlineplus.gov/druginfo/meds/a608045.html.
[2] "Pregnancy Categories." U.S. Food and Drug Administration, FDA, www.fda.gov/media/73131/download.
[3] "Tigecycline." DrugPatentWatch, 2022, drugpatentwatch.com/drugs/tigecycline.